In pancreatic cancer, galectin-1 promotes the secretion of matrix metalloproteinase (MMP9) and IDO [67], and high expression of MMP9 and IDO can result in NK cell dysfunction [65]. This evidence concerns the gene IDO1 and pancreatic neoplasm.